Humacyte Correlations

HUMA Stock

USD 1.01 0.01 0.98%

The current 90-days correlation between Humacyte and Entrada Therapeutics is 0.15 (i.e., Average diversification). The correlation of Humacyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Humacyte Correlation With Market

Weak diversification

The correlation between Humacyte and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Humacyte Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

For information on how to trade Humacyte Stock refer to our How to Trade Humacyte Stock guide.

Moving together with Humacyte Stock

0.71	RAC	Race Oncology	Pair Corr
0.81	VALN	Valneva SE ADR Downward Rally	Pair Corr
0.88	DRMA	Dermata Therapeutics Buyout Trend	Pair Corr
0.8	AVH	Avita Medical	Pair Corr
0.7	PYC	Physiomics Plc	Pair Corr
0.83	VINC	Vincerx Pharma, Common	Pair Corr
0.78	VIVS	VivoSim Labs, Symbol Change	Pair Corr
0.83	DYAI	Dyadic International	Pair Corr
0.75	ALA	Arovella Therapeutics	Pair Corr
0.79	VRAX	Virax Biolabs Group	Pair Corr

Moving against Humacyte Stock

0.76	DSGN	Design Therapeutics	Pair Corr
0.72	VCYT	Veracyte	Pair Corr
0.71	DNTH	Dianthus Therapeutics	Pair Corr
0.65	VCEL	Vericel Corp Ord	Pair Corr
0.61	0P6S	Bayer AG NA	Pair Corr
0.6	DVAX	Dynavax Technologies Trending	Pair Corr
0.57	DRUG	Bright Minds Biosciences	Pair Corr
0.56	VKTX	Viking Therapeutics	Pair Corr
0.55	VERA	Vera Therapeutics	Pair Corr
0.53	DNLI	Denali Therapeutics	Pair Corr
0.46	DMAC	DiaMedica Therapeutics	Pair Corr
0.34	CDIOW	Cardio Diagnostics	Pair Corr
0.86	VRDN	Viridian Therapeutics	Pair Corr
0.82	VTVT	vTv Therapeutics	Pair Corr
0.75	VRTX	Vertex Pharmaceuticals	Pair Corr
0.68	ENTA	Enanta Pharmaceuticals	Pair Corr
0.48	VYNE	Vyne Therapeutics	Pair Corr
0.34	VXRT	Vaxart Inc	Pair Corr
0.34	EFTR	Effector Therapeutics	Pair Corr
0.32	VNDA	Vanda Pharmaceuticals	Pair Corr

Related Correlations Analysis

	TRDA	ARCT	ACHV	VYGR	SGMT	IMRX	VNDA	FHTX	AVIR	NAUT
TRDA		-0.82	0.43	-0.69	-0.68	0.06	0.58	0.44	0.25	0.87	TRDA
ARCT	-0.82		-0.64	0.83	0.32	-0.25	-0.19	-0.26	-0.36	-0.91	ARCT
ACHV	0.43	-0.64		-0.43	0.06	-0.09	0.02	-0.22	0.54	0.62	ACHV
VYGR	-0.69	0.83	-0.43		0.4	-0.45	-0.07	-0.38	-0.15	-0.77	VYGR
SGMT	-0.68	0.32	0.06	0.4		0.05	-0.67	-0.48	0.02	-0.41	SGMT
IMRX	0.06	-0.25	-0.09	-0.45	0.05		-0.38	0.29	-0.19	0.24	IMRX
VNDA	0.58	-0.19	0.02	-0.07	-0.67	-0.38		0.49	0.33	0.25	VNDA
FHTX	0.44	-0.26	-0.22	-0.38	-0.48	0.29	0.49		0.07	0.29	FHTX
AVIR	0.25	-0.36	0.54	-0.15	0.02	-0.19	0.33	0.07		0.29	AVIR
NAUT	0.87	-0.91	0.62	-0.77	-0.41	0.24	0.25	0.29	0.29		NAUT
	TRDA	ARCT	ACHV	VYGR	SGMT	IMRX	VNDA	FHTX	AVIR	NAUT

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NAUT	+ 0.87	TRDA
VYGR	+ 0.83	ARCT
NAUT	+ 0.62	ACHV
VNDA	+ 0.58	TRDA
AVIR	+ 0.54	ACHV
FHTX	+ 0.49	VNDA

High negative correlations

NAUT	- 0.91	ARCT
ARCT	- 0.82	TRDA
NAUT	- 0.77	VYGR
VYGR	- 0.69	TRDA
SGMT	- 0.68	TRDA
VNDA	- 0.67	SGMT

Risk-Adjusted Indicators

There is a big difference between Humacyte Stock performing well and Humacyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Humacyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TRDA	2.91	0.89	0.28	0.74	2.56	(3.45)	7.03	(4.60)	20.54
ARCT	4.87	(1.50)	0.00	(1.03)	0.00	0.00	7.67	(8.56)	61.30
ACHV	3.78	0.49	0.19	0.20	3.14	(4.61)	7.25	(5.87)	46.55
VYGR	2.91	(0.05)	(0.01)	0.03	3.38	(3.26)	6.22	(5.23)	21.00
SGMT	3.57	(0.37)	0.00	(0.05)	0.00	0.00	6.39	(8.25)	36.94
IMRX	3.59	(0.28)	0.00	(0.13)	0.00	0.00	7.18	(8.55)	17.46
VNDA	3.05	0.67	0.13	0.99	4.06	(3.48)	7.11	(5.61)	27.93
FHTX	3.56	0.09	0.03	0.11	4.93	(3.53)	8.01	(7.42)	24.16
AVIR	1.72	0.24	0.09	0.24	2.60	(1.85)	4.38	(2.91)	17.80
NAUT	5.95	1.55	0.22	1.10	5.55	(8.14)	16.32	(12.00)	53.15

Humacyte Corporate Management

Harold Alterson	Senior Quality	Profile
Sabrina Osborne	Executive People	Profile
Dale Sander	Chief CFO	Profile
Heather Connelly	Senior Quality	Profile
William Scheessele	Chief Officer	Profile
Yang MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC